Chemotherapy With CMF for Triple-Negative Breast Cancer With Carcinoma Erysipelatoides

Yen Chi-Feng; Lam Hung-Bun

首页> 外文期刊>JAMA dermatology >Chemotherapy With CMF for Triple-Negative Breast Cancer With Carcinoma Erysipelatoides

【24h】

Chemotherapy With CMF for Triple-Negative Breast Cancer With Carcinoma Erysipelatoides

机译：CMF化学疗法治疗三阴性乳腺癌与Erysipelatoides癌。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《JAMA dermatology》 |2016年第11期|共3页
作者
Yen Chi-Feng; Lam Hung-Bun;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类皮肤病学与性病学;
关键词

相似文献

外文文献
中文文献
专利

1. Chemotherapy With CMF for Triple-Negative Breast Cancer With Carcinoma Erysipelatoides [J] . Yen Chi-Feng, Lam Hung-Bun JAMA dermatology . 2016,第11期

机译：CMF化学疗法治疗三阴性乳腺癌与Erysipelatoides癌。
2. Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281. [J] . Aisner J, Cirrincione C, Perloff M, Journal of Clinical Oncology . 1995,第6期

机译：组合化疗用于乳腺的转移性或复发癌 - 一种随机期III试验比较CAF与Vath与CMFV的vath交替：癌症和白血病组研究8281。
3. Matrix-producing Carcinoma as an Aggressive Triple-negative Breast Cancer: Clinicopathological Features and Response to Neoadjuvant Chemotherapy [J] . Shimada Kazuhiro, Ishikawa Takashi, Yamada Akimitsu, Anticancer Research: International Journal of Cancer Research and Treatment . 2019,第7期

机译：产生基质癌作为激进的三重阴性乳腺癌：临床病理特征和对新辅助化疗的反应
4. Optical coherence elastography as a new method for estimation of chemotherapy efficacy on triple-negative breast cancer in the experiment [C] . Anton A. Plekhanov, Marina A. Sirotkina, Alexander A. Sovetsky, International Symposium on Optics and Biophotonics: Saratov Fall Meeting . 2019

机译：光学相干弹性造影作为对实验中三阴性乳腺癌化疗疗效估算的新方法
5. Preclinical exploration of novel small molecules as anticancer agents in triple-negative and HER2/neu-positive breast cancers. [D] . Weng, Shu-Chuan. 2008

机译：在三阴性和HER2 / neu阳性乳腺癌中作为抗癌药的新型小分子的临床前探索。
6. Response of a chemo-resistant triple-negative breast cancer patient to a combination of p62-encoding plasmid Elenagen and CMF chemotherapy [O] . Dmitry M. Ponomarenko, Vladimir L. Gabai, Albert A. Sufianov, 2020

机译：化疗耐药的三阴性乳腺癌患者对p62编码质粒Elenagen和CMF化疗联合使用的反应
7. Response of a chemo-resistant triple-negative breast cancer patient to a combination of p62-encoding plasmid, Elenagen, and CMF chemotherapy [O] . Dmitry M. Ponomarenko, Vladimir L. Gabai, Albert A. Sufianov, 2020

机译：化学抗性三重阴性乳腺癌患者对P62编码质粒，ELENAGEN和CMF化疗的组合的反应

Chemotherapy With CMF for Triple-Negative Breast Cancer With Carcinoma Erysipelatoides

著录项

相似文献

相关主题

期刊订阅